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Abstract
Malaria is among the most serious infectious diseases affecting humans, accounting for 
approximately half a million deaths annually1. Plasmodium falciparum is the causative agent of 
most life-threatening malaria cases. Acquired immunity to malaria is inefficient, even after 
repeated exposures to P. falciparum2; immune regulatory mechanisms employed by P. falciparum 
remain largely unclear. Here, we show that P. falciparum uses immune inhibitory receptors for 
immune evasion. RIFINs, products of a polymorphic multigene family comprising approximately 
150–200 genes per parasite genome3, are expressed on the surface of infected erythrocytes. We 
found that a subset of RIFINs binds to either leucocyte immunoglobulin-like receptor B1 
(LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAIR1). LILRB1-binding 
RIFINs inhibited activation of LILRB1-expressing B cells and NK cells. Furthermore, interactions 
between LILRB1 and P. falciparum-infected erythrocytes isolated from malaria patients were 
associated with severe malaria, although an extended study with larger sample sizes is required to 
confirm the findings. These results suggest that P. falciparum has acquired multiple RIFINs to 
evade the host immune system by targeting immune inhibitory receptors.
P. falciparum employs multiple strategies of immune evasion throughout its different 
developmental stages. Central to parasite survival is the invasion of erythrocytes, within 
which parasites replicate, while largely protected from immune attack. Blood-stage parasites 
cause malarial pathology and are the major targets of cellular and acquired antibody-
mediated immunity4,5. P. falciparum-infected erythrocytes (IEs) express members of the 
polymorphic PfEMP1, RIFIN and STEVOR6 protein families on the IE surface. PfEMP1 
bind endothelial receptors to sequester IEs from blood circulation, allowing parasites to 
escape splenic clearance7. RIFIN and STEVOR functions are unclear, although single 
members of these protein families bind uninfected erythrocytes to form so-called rosettes8 
that may facilitate sequestration and evasion of immune recognition in vivo9.
Host immune cells express diverse inhibitory receptors specific for self-antigens to down 
regulate autoimmune responses. Some viruses exploit these inhibitory receptors for immune 
evasion by mimicking corresponding ligands10. We hypothesised that P. falciparum similarly 
exploits inhibitory receptors by expressing parasite-derived ligands on IEs to impair immune 
responses. We therefore analysed the binding of 13 Fc-fused human inhibitory receptors to 
erythrocytes infected with the P. falciparum laboratory strain 3D7 or P. falciparum isolated 
from patients with malaria. In this screen, leucocyte immunoglobulin-like receptor B1 
(LILRB1) was the only receptor that exhibited detectable increased binding to a small 
fraction of IEs (Extended Data Fig. 1).
Next, we investigated whether LILRB1 bound erythrocytes infected with P. falciparum 
isolates acquired from seven Thai patients with malaria. We found that LILRB1 bound a 
large fraction (77%) of IEs from patient 6 and a small fraction from patients 1 (32%) and 4 
(15%) (Fig. 1a and Extended Data Fig. 2a). LILRB1, also known as ILT2, CD85j or LIR-1, 
is an inhibitory receptor of the LILR family expressed on diverse immune cells and encoded 
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by genes within the leucocyte receptor complex (LRC) region11. LILRB1, which recognises 
MHC I molecules12, binds the MHC class I-like UL1813 encoded byhuman 
cytomegalovirus, suggesting that the LILR family coevolved with microbial pathogens11,14. 
Binding of LILRB1 to IEs was primarily observed at the middle trophozoite and schizont 
stages of P. falciparum development (Fig. 1b and Extended Data Fig. 2b). LILRB1 bound to 
IE subpopulations of four P. falciparum laboratory strains (Fig. 1c and Extended Data Fig. 
2c). Erythrocytes do not express HLA class I molecules, indicating that a parasite-derived 
molecule served as an LILRB1 ligand.
The P. falciparum genome does not encode an MHC class I-like gene15. Thus, to identify 
putative LILRB1 ligands on IEs, we took advantage of 3D7 parasites, for which whole-
genome sequence data are available. LILRB1-Fc bound to a small proportion of 3D7 IEs. 
We therefore enriched 3D7 IEs for LILRB1-binding using cell sorting and subsequently 
subcloned 3D7 parasites using limiting dilution to obtain LILRB1-binding (F2) and non-
binding (D11) parasite clones (Fig. 1d). Proportions of LILRB1-binding IEs (F2) decreased 
during passage after cloning (Extended Data Fig. 2e), suggesting that the expression of 
putative LILRB1 ligands was regulated by transcriptional switching between members of a 
P. falciparum multigene family. To identify putative LILRB1 ligands on IEs, we conducted 
mass spectrometric analyses of proteins co-precipitated with LILRB1-Fc from 3D7 F2 and 
D11 clones (Extended Data Fig. 3a). In two independent experiments, only one peptide 
(FHEYDER) matching those of RIFINs was specific to F2 immunoprecipitates (Extended 
Data Fig. 3b, 3c and Supplementary Table 1).
RIFINs are encoded by 150–200 rif genes per parasite genome3. The FHEYDER sequence 
is shared among 36 different RIFINs in the 3D7 genome. Therefore, cloning of these rif 
genes was performed to assess RIFIN binding to LILRB1. We cloned 25 and 6 rif genes 
with or without the FHEYDER sequence, respectively. Erythrocytes infected with 3D7 
parasites transfected with each rif gene (Supplementary Table 2) were screened for binding 
to LILRB1-Fc (Extended Data Fig. 4a). IEs transfected with RIFIN #1–2 (PF3D7_1254800; 
PF3D7_0223100 )bound strongly to LILRB1-Fc, whereas IEs transfected with RIFINs #3–5 
(PF3D7_0500400; PF3D7_1000500; PF3D7_1254200) did not (Fig. 2a and Extended Data 
Fig. 4a). Presence of the FHEYDER sequence in the transfected RIFINs was not associated 
with LILRB1-Fc binding (Fig. 2b and Extended Data Fig. 4a). Gene expression levels of 
LILRB1-Fc non-binding RIFINs (LILRB1− RIFINs) #3–5 were similar or higher than those 
of LILRB1-Fc-binding RIFINs (LILRB1+ RIFINs) #1 and #2 (Extended Data Fig. 5a). To 
validate the findings, we generated transgenic parasites expressing C-terminally His-tagged 
RIFINs #1, #2 or #5 (Extended Data Fig. 5b). Again, IEs transfected with RIFINs #1 and #2, 
but not RIFIN #5, bound to LILRB1-Fc (Extended Data Fig. 5c). These results indicate that 
a subset of RIFINs on IEs acts as LILRB1 ligands.
The extracellular domain of RIFINs comprises a relatively conserved N-terminal region 
containing the FHEYDER sequence and a highly variable C-terminal region (Fig. 
2b).LILRB1-Fc bound to the variable and not the conserved region of LILRB1+ RIFIN #1 
expressed on 293T cells (Fig. 2c). Further, recombinant LILRB1+ RIFIN #1 protein, but not 
LILRB1− RIFIN #5, bound to LILRB1 expressed on transfected 293T cells (Fig. 2d and 
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Extended Data Fig. 6). These results indicate that RIFINs interact directly with LILRB1 
through specific amino acids or conformations within their variable region.
The LILR family comprises five activating, five inhibitory and one soluble form. LILRB1 
shares >80% sequence identity with the activating LILRA2 receptor that recognises 
microbially cleaved immunoglobulins14. LILRA2 and other LILRs did not bind LILRB1+ 
RIFIN #1 expressed on 293T cells (Extended Data Fig. 7a). Similarly, LILRB1 was the only 
LILR family member that bound erythrocytes infected with RIFIN #1-transgenic parasites 
(Extended Data Fig. 7b). No LILR bound erythrocytes infected with RIFIN #5-transgenic 
parasites (Extended Data Fig. 7b). These data suggest that certain RIFINs evolved to 
specifically interact with LILRB1. Natural ligands for LILRB1 are HLA class I molecules12. 
However, LILRB1+ RIFINs or LILRB1− RIFINs do not share amino acid sequence 
similarities or predicted structural homology with HLA class I molecules as indicated by 
results of a search using Phyre2. Further, we could not identify amino acid sequence motifs 
characteristic of LILRB1+ RIFINs. Similar to the recent determination of the protein 
structure of PfEMP1-host receptor interactions16,17, solving the structure of the LILRB1–
RIFIN interaction may clarify molecular constraints that confer receptor-binding specificity 
and antigenic diversity of RIFINs.
LAIR1 is an inhibitory receptor for collagens encoded within the LRC, similar to LILRB1, 
suggesting that these genes are evolutionarily related18. Unique antibodies isolated from 
individuals living in a malaria-endemic region contained a mutated LAIR1 insert that bound 
RIFIN #6 (PF3D7_1400600) and RIFIN #7 (PF3D7_1040300), whereas binding of wild-
type LAIR1 to these RIFINs was undetectable or weak19,20. Three amino acid substitutions 
in the mutated LAIR1 (T67L/N69S/A77T) are responsible for its increased binding to 
RIFINs. Consistent with previous observations19,20, mutated LAIR1 (T67L/N69S/A77T)-Fc 
bound IEs from parasites transfected with RIFINs #6 and #7, but not wild-type LAIR1-Fc 
(Extended Data Fig. 8a). However, when analysing the binding of wild-type LAIR1 to IEs 
from 15 RIFIN-transgenic parasite lines (Extended Data Fig. 4b),we found that LAIR1-Fc 
bound to IEs from parasites transfected with LILRB1−RIFIN #8 (PF3D7_1101100) (Fig. 
2a). Moreover, wild-type LAIR1-Fc bound 5%–78% of erythrocytes infected with parasites 
from Thai malaria patients (Extended Data Fig. 8b).
When IE binding of both LILRB1-Fc and LAIR1-Fc was analysed using parasites isolated 
from three patients, IEs derived from patient 1 predominantly bound LILRB1-Fc and 
LAIR1-Fc, whereas IEs derived from patients 5 and 6 predominantly bound LAIR1-Fc or 
LILRB1-Fc, respectively (Extended Data Fig. 8c). Similar to LILRB1+ RIFINs, structural 
homology to natural ligands for LAIR1 (collagens)21 was not predicted from our analysis of 
the LAIR1-binding (LAIR1+) RIFIN #8 sequence. Consistent with previous studies of 
RIFIN expression22,these results suggest that RIFINs are expressed on IE cell surface in a 
variegated manner and that P. falciparum evades immune attack through the interaction of 
RIFIN with different inhibitory receptors.
Next, we investigated whether RIFINs induced LILRB1- or LAIR1-mediated cell signalling 
using the nuclear factor of activated Tcells (NFAT)-GFP reporter system wherein GFP 
expression is induced upon ligand interaction with LILRB1 or LAIR114,23,24 (Fig. 3a). 
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When the LILRB1-reporter cells were co-cultured with immobilised recombinant RIFINs, 
the cells were activated, and GFP expression was induced by LILRB1+ RIFIN #1 but not by 
LILRB1− RIFIN #5 (Fig. 3b). Moreover, when LILRB1-reporter cells were co-cultured with 
erythrocytes infected with RIFIN-transgenic parasites, LILRB1-reporter cells were activated 
by IEs expressing LILRB1+ RIFIN #1 but not by IEs expressing LILRB1− RIFIN #4 (Fig. 
3c and Extended Data Fig. 2d). In contrast, IEs expressing LAIR1+ RIFIN #8 did not 
significantly stimulate LAIR1-reporter cells, whereas collagen, a host ligand for LAIR1, 
significantly stimulated the reporter cells (Extended Data Fig. 9a). Similarly, IEs derived 
from patient 1 and LAIR1+ IEs enriched from patient 4 IEs using cell sorting did not 
significantly stimulate LAIR1-reporter cells (Extended Data Fig.9b and 9c). These results 
suggest that the LAIR1–RIFIN interaction was not sufficiently strong to deliver inhibitory 
signals that were detectable in this assay. However, the LAIR1–RIFIN interaction may 
transduce an inhibitory signal via LAIR1 in other in vivo situations.
LILRB1 is expressed on various immune cell types, including T cells, B cells, natural killer 
(NK) cells and monocytes. LILRB1 expressed by primary human B cells is involved in 
suppressing B cell responses25. We therefore examined the effects of RIFINs on B cells 
expressing LILRB1 (Fig. 3d). IEs expressing LILRB1+ RIFIN #1, but not LILRB1− RIFIN 
#4, inhibited IE-induced immunoglobulin M (IgM) production26 of primary human B cells 
present in preparations of peripheral blood mononuclear cells (PBMCs) (Fig. 3e). Similarly, 
CHO cells expressing LILRB1+ RIFIN #1, but not LILRB1− RIFIN #3, inhibited IgM 
production by PBMCs (Fig. 3f). We next investigated the effects of LILRB1+ RIFIN #1 and 
LILRB1− RIFIN #5 on the cytolytic function of an LILRB1-expressing human NK cell line, 
NKL (Extended Data Fig. 9d). K562 cells, often used as targets for NK cells, stably 
transfected with LILRB1+ RIFIN #1 were more resistant to NK-mediated killing than 
parental or K562 cells stably transfected with LILRB1−RIFIN #5, suggesting that NK cell 
response is down regulated by the LILRB1–RIFIN interaction (Extended Data Fig. 9e and 
9f). These results indicate that malaria parasites use RIFINs to down regulate immune cells 
and impair anti-malarial immunity.
These data led us to hypothesise that IE binding to LILRB1 contributes to parasite survival 
during infection and is potentially associated with development of severe malaria. To 
evaluate this hypothesis, we analysed LILRB1 binding to IEs from Tanzanian patients with 
malaria. A significantly higher number of IEs from patients with severe malaria (cerebral 
malaria or severe malarial anaemia) bound to recombinant LILRB1-Fc compared with IEs 
from patients without these severe forms of malaria (Fig. 4a).The median number of IEs 
binding to the LILRB1-Fc from non-severe malaria patients was close to zero when 
compared to the control-Fc. This finding indicates that IEs from patients with severe malaria 
more often express LILRB1+ RIFINs and that LILRB1-binding IEs contribute to the 
pathogenesis of severe malaria. However, the sample size in this study was small, and further 
studies are required to clarify LILRB1's role in the pathogenesis of malaria.
Variation of P. falciparum surface antigens in vivo is governed by the host's immune 
status27,28. In areas with high P. falciparum transmission, immunity to severe malaria is 
acquired early in life and before acquisition of clinical immunity2. Thus, antibodies against 
RIFIN subsets associated with severe malaria may be acquired early and before antibodies to 
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other RIFINs. Therefore, we analysed IgG reactivity with recombinant proteins derived from 
the RIFIN-variable regions of LILRB1+ RIFIN #1 and LILRB1− RIFIN #5 in plasma from 
222 Tanzanians. IgG acquisition was similar for the two RIFINs, and as previously reported 
for another RIFIN29, with a very early and marked increase in the proportion of individuals 
responding to the RIFINs one year after birth, plateauing thereafter (Extended Data Fig. 10). 
Though antibody acquisition was similar for the two RIFINs, the rapid acquisition of 
antibodies suggests that RIFINs play an active role in early infections and may serve as 
important targets of protective immunity.
RIFIN-binding antibodies with LAIR1 inserted into their variable regions19, appear to be 
produced in response to P. falciparum infection20, potentially to inhibit the interaction 
between RIFINs and native LAIR1. These findings and data presented here suggest that 
RIFINs evolved to bind inhibitory receptors to facilitate an escape from the host immune 
system (Fig. 4b). RIFINs are unique to P. falciparum but belong to the Plasmodium 
interspersed repeats (pir) protein super family encoded by multigene families present in all 
human- and rodent-specific species of Plasmodium (e.g., vir of P. vivax, kir of P. knowlesi 
and cir/bir/yir of rodent malaria parasites30). Studies of immune receptor interactions with 
these polymorphic protein families may further identify crucial host–parasite interactions in 
the regulation of malarial infections.
Methods
Cells
Human embryonic kidney 293T and Chinese hamster ovary (CHO) cells were obtained from 
and authenticated by the RIKEN Cell Bank. NKL cells31 were a gift from Dr. Lanier 
(University of California, San Francisco). The K562 cell line was obtained from the Cell 
Resource Centre for Biomedical Research, Institute of Development, Ageing and Cancer, 
Tohoku University. PBMCs were separated from the blood of healthy donors using Ficoll 
density gradient centrifugation (GE Healthcare, Pittsburgh, PA, USA). Each cell line was 
tested regularly for Mycoplasma contamination using PCR.
Collection of P. falciparum parasites from Thai patients with malaria
All clinical P. falciparum isolates were acquired from patients living in the Mae Sariang 
district, Mae Hong Son Province in Thailand according to the ethical guidelines described 
below. Clonal parasite lines were established from field-isolated parasites using limiting 
dilution. All parasite strains were cultivated with human erythrocytes (type O blood, 
haematocrit [Ht] 2%, the Japanese Red Cross Blood Centre) in complete medium, which 
consisted of RPMI-1640 medium containing 20% Albu MAX I (Life Technologies), 25 mM 
HEPES, 0.225% sodium bicarbonate and 0.38 mM hypoxanthine supplemented with 10g/ml 
gentamicin. Strains were incubated in an atmosphere containing 90% N2, 5% CO2 and 5% 
O2.
P. falciparum culture
The P. falciparum strains 3D732, CDC133, K134, FCR334, Dd232 and parasites from Thai 
patients were cultured with human erythrocytes in RPMI-1640 containing 10% human 
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serum. Transgenic parasites were maintained in RPMI-1640 containing 10% human serum 
and 25 ng/ml pyrimethamine (Sigma-Aldrich). Parasites were synchronised at the ring stage 
using 5% D-sorbitol, and trophozoite- and schizont-stage parasites were enriched using 
Percoll density gradient centrifugation (GE Healthcare). Parasite cultures were tested 
routinely for Mycoplasma contamination using PCR.
Cloning of P. falciparum 3D7 parasites
The 3D7 parasite cultures enriched for LILRB1-binding IEs were generated by sorting cells 
that bound LILRB1-Fc fusion protein pre-mixed with anti-IgG Fc-APC antibodies. These 
enriched IEs were then subjected to limiting dilution to obtain a single clone. Briefly, the 
enriched parasites were synchronised at the ring stage using 5% D-sorbitol. After 48 h, 
parasites at the late schizont stage were purified using 63% (v/v) Percoll (Amersham 
Pharmacia Biotech) density gradient centrifugation. The parasites in culture media (10% O-
type human serum in RPMI 1640; GIBCO BRL) were mixed with freshly prepared human 
erythrocytes and cultured in a T-75 flask (parasitemia, 1%; haematocrit, 2%). One hour after 
incubation at 37°C in an atmosphere containing 5% CO2, 5% O2 and 90% N2 (CO2-O2-N2 
incubator BNP-110, TABAI ESPEC Corp), the cap of the flask was tightly sealed, and the 
flask was shaken on an orbital shaker at 100 rpm to avoid multiple infections of a single 
erythrocyte. The parasite stage was monitored every 2 h using Giemsa staining, and after 
most parasites proceeded to the ring stage, the parasite culture was diluted using fresh 
culture media with erythrocytes (3% haematocrit). The diluted parasites (0.5 parasite/0.2 ml) 
were plated in 96-well flat bottom plates, and 50% of the culture medium was changed every 
48 h. After 2 weeks in culture, parasites were detected in approximately 20 wells per plate, 
and LILRB1-binding positive and negative wells were screened using flow cytometric 
analysis. LILRB1+ F2 and LILRB1− D11 clones were obtained using this procedure.
Plasmids
Plasmids for paired immunoglobulin-like type 2 receptor (PILR)α-Fc, CD200R-Fc and 
LILR-Fc fusion protein production were constructed as previously described14,35,36. 
Plasmids for LAIR1 (GenBank: AF013249.1, amino acid residues 23-165), KIR2DL1*003 
(amino acid residues 22-245), KIR2DL2*001 (amino acid residues 22-245), KIR2DL3*001 
(amino acid residues 22-245), KIR2DL4*001 (amino acid residues 24-240), KIR2DL5*001 
(amino acid residues 22-239) and KIR3DL1*001 (amino acid residues 22-339) were 
constructed in the same manner. Fc fusion proteins of these inhibitory receptors were used 
for analyses of binding to IEs. A plasmid encoding a mutated LAIR1 (T67L/N69S/A77T) 
Fc-fusion protein was generated using site-directed mutagenesis of the wild-type LAIR1 and 
a QuikChange Multi Site-Directed Mutagenesis Kit (Agilent Technologies). To produce a 
biotinylated LILR-Fc fusion protein, C-terminally AviTagged-LILR-Fc plasmids were 
constructed via insertion into a pCAGGS expression vector. To generate transgenic parasites, 
full-length genome sequence of RIFINs, including an intron, were obtained using PCR 
amplification of the 3D7 genome with primer sets (Supplementary Table 3) and inserted into 
the PfCEN5 expression vector. Each RIFIN-PfCEN5 expression vector was cloned in 
Escherichia coli and subjected to Sanger sequencing (Supplementary Sequence 
Chromatogram). Each rif sequence was compared with the 3D7 genome version 3 (release 
32, PlasmoDB, http://plasmodb.org). For RIFINs that were unexpectedly cloned because of 
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sequence similarity their 5′ and 3′ termini, nucleic acid sequences of primer annealing sites 
were replaced with primer sequences. However, sequences of conserved and variable regions 
were identical to the reference sequences. Silent and missense mutations in the cloned 
RIFINs are summarised in Supplementary Table 2. As a mock control, we used a PfCEN5 
expression vector containing GFP. To confirm that the first intron in the rif transgenes was 
correctly spliced out of their IE-transcripts, cDNAs synthesised from RIFIN #1∼5 and #8-
transgenic IEs were amplified using PCR with the primers (5′-
TTATCCTTATTTTTTAATAACTGCC-3′ and 5′-GTTCGTGGCATTCCAC-3′), followed 
by direct sequencing of the amplicons. As shown in Supplementary Sequence 
Chromatogram, the first intron was correctly spliced out of their transcripts, resulting in in-
frame transcripts. A structural homology search of RIFINs was conducted using Phyre2 
(http://www.sbg.bio.ic.ac.uk/phyre2). C-terminal His-tagged RIFINs #1, #2 and #5 were 
constructed based on these cloned RIFIN-PfCEN5 expression vectors. Full-length RIFIN #6 
(PF3D7_1400600) and RIFIN #7 (PF3D7_1040300) were synthesised by IDT and 
GenScript, respectively, and cloned into the PfCEN5 expression vector. For cell surface 
expression of RIFINs on 293T and CHO cells, the extracellular domains of RIFIN #1 
(amino acid residues 166–275) and RIFIN #3 (amino acid residues 166–331) linked to the 
transmembrane and cytoplasmic regions of PILRα (amino acid residues 196–256)37 were 
cloned into a pME18s expression vector37. N-terminal conserved and C-terminal variable 
regions of RIFIN #1 corresponding to amino acid residues 39–139 and 166–275, 
respectively, were expressed with the transmembrane and cytoplasmic regions of PILRα 
using the pME18s expression vector, respectively. To generate recombinant RIFIN #1 
(amino acid residues 166–275) and #5 (amino acid residues 168-309) using a wheat germ 
cell-free protein expression system, C-terminal His-tagged RIFINs were constructed by 
synthesising codon-optimised versions of the rif gene (https://
www.eurofinsgenomics.com/en/home.aspx), followed by insertion into a pEU-E01 
expression vector (CellFree Sciences). To generate recombinant RIFIN #1 (amino acid 
residues 166–275) and #5 (amino acid residues 168–309) in E. coli, N-terminal His-tagged 
RIFINs were constructed by synthesising codon-optimised versions of rif genes (IDT), 
followed by insertion into the pET-15b vector (N-terminal His-tagged cassette).
Transfection
The transient transfection of plasmids into 293T and CHO cells was conducted using PEI 
Max (Polysciences Inc.). For 293T cell surface expression, plasmids encoding target 
molecules and GFP were used to co-transfect 293T cells, and GFP-positive cells were 
analysed as previously described38. To express RIFINs on the cell surface of CHO cells, 
plasmids encoding fusion proteins comprising RIFINs and the transmembrane and 
cytoplasmic domains of mouse PILRα or mock (human melanoma differentiation-associated 
protein 5 (MDA5) were used to co-transfect CD8 into CHO cells. Stable transfectants of 
K562-RIFIN #1 (amino acid residues 166–275) and #5 (amino acid residues 168-309) were 
generated using retrovirus-mediated transduction with the pMxs retroviral expression vector 
and PLAT-E retroviral packaging cells transfected with an amphotropic envelope as 
previously described39.
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Flow cytometry
The binding of human receptor-Fc fusion proteins to IEs was examined by staining IEs with 
Fc fusion proteins premixed with an allophycocyanin (APC)-conjugated anti-human IgG Fc 
antibody (109-136-098, Jackson Immuno Research Laboratories). For PILRα-Fc fusion 
protein, cells were mixed with PILRα-Fc fusion protein followed by APC conjugated anti-
human IgG Fc antibody to decrease non-specific staining. For double staining of IEs with 
LAIR1-Fc and LILRB1-Fc fusion proteins, the LAIR1-Fc or LILRB1-Fc fusion protein was 
mixed with an APC-conjugated anti-human IgG Fc antibody or an phycoerythrin (PE)-
conjugated anti-human IgG Fc antibody (109-116-098, Jackson Immuno Research 
Laboratories), respectively, followed by blocking these complexes with purified human IgG 
(Cappel). Thereafter, IEs were stained with these complexes. The LILRA2-Fc fusion protein 
was used as a control. The binding of His-tagged recombinant RIFINs to LILR-transfected 
293T cells was analysed by staining with recombinant His-tagged RIFINs, followed by 
detection with an anti-His antibody (clone 28-75; WAKO) or an anti-DYKDDDDK (FLAG) 
antibody (clone L5; Biolegend). Nuclei of IEs were stained using Vybrant Green (Thermo). 
Populations of IEs or reporter cells were gated using FSC and SSC parameters 
(Supplementary gating strategy for flow cytometry analysis). Flow cytometric analyses were 
conducted using BD FACS Calibur, LSR II and FACS Verse flow cytometers (BD 
Biosciences). Data were analysed using FlowJo software (FlowJo, LLC).
Preparation of infected red cell ghosts
P. falciparum-infected red cells were incubated for 15 min at 4 °C in 40 volumes of 
hypotonic solution (RPMI-1640 diluted 5-fold in water). Ghost cells were collected by 
centrifugation at 15,000 rpm for 15 min and washed three times with a hypotonic solution.
Biotinylation of LILRB1-Fc protein and immunoprecipitation
Purified AviTag-LILRB1-Fc was biotinylated using BirA biotin-protein ligase (Avidity) 
(Extended Data Fig. 3a). Red cell ghosts obtained from erythrocytes infected with the 
LILRB1+ F2 or LILRB1− D11 clone at the schizont-stage were incubated with biotinylated 
LILRB1-Fc fusion protein and subsequently treated with 0.25 mM 3,3-dithiobis 
(sulfosuccinimidyl propionate) (DTSSP, Thermo Scientific) to generate crosslinks. Red cell 
ghosts treated without LILRB1-Fc were used as controls. The red cell ghosts were then 
washed in phosphate-buffered saline, solubilised by boiling in sample buffer in the absence 
of 2-mercaptoethanol and immunoprecipitated using streptavidin Sepharose (GE 
Healthcare). The immunoprecipitated products were eluted using 50 mM dithiothreitol 
(DTT) and analysed using a liquid chromatography-tandem mass spectrometer (LC-MS/MS, 
LTQ Orbitrap, Thermo Scientific) after tryptic digestion. All MS/MS spectra data were 
analysed using Mascot software (Matrix Science) with the 3D7 sequence database version 3 
(PlasmoDB, http://plasmodb.org). Proteins detected in control precipitates from F2 and D11 
clones and LILRB1-Fc precipitates from D11 clone were considered non-specific (Extended 
Data Fig. 3b, 3c and Supplementary Table 1).
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Generation of transgenic parasites
Transgenic parasites were generated as previously described40. Briefly, fresh erythrocytes 
were transfected with the RIFIN-PfCEN5 plasmid via electroporation and subsequently 
infected with 3D7 parasites. Four days later, the parasites were cultured in RPMI-1640 
containing pyrimethamine. Transcription of the rif transgenes was controlled by the 
promoter for the P. berghei elongation factor-α. These RIFIN-PfCEN5 plasmids can be 
maintained stably in an episomal form in the parasite during multiple rounds of cell division.
Quantitative PCR
Trophozoite-stage P. falciparum-infected erythrocytes were cultivated and subjected to RNA 
extraction using TRIzol (Thermo Fisher Scientific) according to the manufacturer's 
instructions. Contaminating genomic DNA was removed from extracted RNA using the 
TURBO DNA-free kit (Thermo Fisher Scientific) according to the manufacturer's 
instructions. The absence of detectable DNA in extracted RNA was confirmed using PCR 
with a primer set specific for the seryl-tRNA synthetase gene as previously described41. The 
cDNA was synthesised using SuperScript III (Thermo Fisher Scientific) and random 
hexamers according to the manufacturer's instructions. Quantitative PCR was performed for 
the rif transgene transcripts using Power SYBR Green Master Mix (Thermo Fisher 
Scientific) with primers (5′-AGGAATAAAGTGAATGGAGTCGA-3′ and 5′-
AGCTTCGATCAAATGTGGTGG-3′) located within the 3′ UTR of the P. berghei heat 
shock protein, located downstream of the rif transgenes. The seryl-tRNA synthetase gene 
was used as internal control. Relative expression was calculated using theΔCT method. 
Briefly, the expression level of each transgene was normalised to that of the internal control 
using their threshold cycle (Ct) values, and then the relative expression levels of eight 
different transgenes were calculated, defining the average of the RIFIN#1 expression level = 
1.
Recombinant proteins
Fc fusion proteins were produced in 293T cells using transient transfection and purified 
using protein A Sepharose (GE Healthcare) as previously described14. Recombinant RIFINs 
were produced in E. coli BL21 (DE3) via IPTG induction, followed by TALON metal 
affinity chromatography (Takara) purification and subsequent protein refolding. Briefly, 
inclusion bodies were obtained from IPTG-induced cells by disruption using a sonicator and 
were washed with 0.5% Triton X-100. The inclusion bodies were then solubilised with 6 M 
guanidinium hydrochloride and subjected to TALON metal affinity chromatography to 
purify the denatured RIFINs, which were refolded as previously described42. Final 
purification of the recombinant LILRB1+ RIFIN #1 (PF3D7_1254800) and LILRB1− 
RIFIN #5 (PF3D7_1254200) was achieved using gel filtration chromatography through a 
Superdex 200 Increase 10/300 GL column (GE Healthcare) equilibrated with phosphate-
buffered saline. Both proteins eluted as monodisperse peaks, indicating the lack of misfolded 
aggregates. These proteins were analysed using SDS-PAGE and Oriole staining (Bio-Rad, 
Extended Data Fig. 6b and Supplementary Data). The structural integrity of the refolded 
RIFINs was further evaluated according to their circular dichroism (CD) spectra. Briefly, 
proteins were diluted to 0.2 mg/ml with 20 mM phosphate buffer (pH 7.4), and far-UV CD 
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spectra (190–250 nm) were recorded using a Jasco J-820 spectropolarimeter (Jasco Co., 
Ltd.) with a 1-mm path length quartz cell at 25 °C. The spectra are expressed as the mean 
residue ellipticity after subtracting the solvent background. Both #1 and #5 RIFINs exhibited 
CD spectra typical for well-folded proteins with α-helical(208+222 nm) and β-sheet (215 
nm) structures (Extended Data Fig. 6c). Prediction of the secondary structures for each 
RIFIN using the BeStSel server (http://bestsel.elte.hu/index.php) yielded α/β values of 
∼30%/∼10% and ∼30%/∼20% for RIFINs #1 and #5, respectively. Recombinant RIFINs 
from the wheat germ cell-free protein expression system (CellFree Sciences) were produced 
as previously described43.
Reporter Assay
The LILRB1- and LAIR1- reporter cells were mouse T cell hybridomas that were stably 
transfected with NFAT-GFP, FLAG-tagged DAP12 and a fusion of the extracellular domain 
of LILRB1 or LAIR1 with the transmembrane and intracellular domains of paired 
immunoglobulin-like receptor β (PILRβ) as previously described24. The transmembrane and 
cytoplasmic domains of PILRβ were used to induce GFP via the DAP12 adaptor molecule in 
the reporter cells. LILRB1- and LAIR1-reporter cells were immobilised on a 96-well plate at 
1 × 105 cells per well and cultured with stimulants for 16 h. Recombinant RIFINs (10 μg/ml) 
or Type IV collagen (10 μg/ml, Sigma-Aldrich) were immobilised on the plate before 
stimulation. GFP expression was analysed using flow cytometry.
IgM production by RIFIN-stimulated B cells
For stimulation with IEs, PBMCs were co-cultured with IEs at 1:100 for 16 h, washed and 
then cultured for 3 days. IgM levels in the supernatants were determined using an enzyme-
linked immunosorbent assay (ELISA). For stimulation with RIFIN-expressing CHO cells, 
CD8- and RIFIN-positive CHO cells were separated using an auto MACS Pro Separator 
(Miltenyi Biotec) as previously described44 and co-cultured with PBMCs at 1:2. After 24 h, 
the PBMCs were stimulated with K3 CpG (2 μg/ml). After 3 days, IgM levels in the culture 
supernatants were analysed using the ELISA. MDA5 was used as an unrelatedgene (mock 
control).
Cytotoxicity assay
The human erythroleukemia cell line K562, which serves as a target cell for NK cell killing 
assays, was stably transfected with LILRB1+ RIFIN #1 or LILRB1–RIFIN #5 fused with 
transmembrane and cytoplasmic regions of PILR α and labelled with 15 μM Calcein AM 
(Thermo Fisher Scientific) in complete medium (RPMI-1640 without phenol red, 
supplemented with heat-inactivated 10% FCS) for 30 min at 37°C. After washing twice with 
complete medium, cells were adjusted to 5 × 103/100 μl. The NKL effector cells were 
washed twice with complete medium and mixed with target parental or rif-transfected K562 
cells in a round-bottom 96-well plate with E:T ratios ranging from 50:1 to 12.5:1 in 
triplicate. The assay was also performed for spontaneous and maximum release (target cells 
in 2% Triton X-100-containing complete medium). Cells were centrifuged at 100×g for 5 
min and incubated at 37°C in an atmosphere containing 5% CO2 atmosphere for 4 h. After 
incubation, cells were centrifuged at 1500 rpm for 2 min, and the fluorescence of the 
supernatants were measured using a TriStar LB941 (Berthold Technologies). Percent-
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specific lysis was calculated as follows, [experimental release - spontaneous release]/
[maximum release - spontaneous release]× 100.
Binding assay
Parasites collected from Tanzanian paediatric patients with malaria were isolated and 
cultured as previously described45. Binding assays were performed using freshly isolated 
parasites within 24 h of culturing in petri dishes coated with LILRB1-Fc or LILRA2-Fc (as a 
control) as previously described46. Unbound parasites were washed away, while bound 
parasites were fixed with glutaraldehyde, stained with Giemsa and counted. Cerebral malaria 
and severe anaemia were defined according to a Blantyre coma score <3 and blood 
haemoglobin <5 g/dl, respectively, as previously described47. A statistical method was not 
used to specify sample size.
Serological analyses
For this study, 222 plasma samples from children and adults, 6 months to 60 years, were 
collected in Mkokola, Tanzania in 2004. Frozen samples were thawed and analysed for the 
presence of IgG reacting with recombinant RIFIN as previously described48. Antibody 
reactivity was measured in a bead-based Luminex assay, using beads coated with the 
variable regions of LILRB1+ RIFIN #1 (PF3D7_1254800), LILRB1− RIFIN #5 
(PF3D7_1254200) and GLURP R2, which was used as a marker of exposure. The cut-off 
was determined according to mean reactivity +2 SD of 43 European donors never exposed to 
malaria.
Ethics approvals
Ethics approvals for the collection of parasite-infected blood from Thai patients were 
granted by the Research Ethics Committees of the Faculty of Medicine, Chiang Mai 
University (permission number: 187/2554) and the Department of Medicine, Mie University, 
Japan (permission number: 1312). The work was conducted in compliance with all relevant 
ethical standards and regulations governing research involving human samples. Written 
informed consent was obtained from all patients or the parents or guardians of paediatric 
patients. Erythrocytes were obtained from the Japanese Red Cross (research ID: 25J0143). 
Written informed consent was obtained from the parents or legal guardians of the paediatric 
Tanzanian patients. All patients received treatment according to national guidelines. The 
study protocols were reviewed and approved by the National Health Research Ethics 
Committee (NatHREC), hosted by the National Institute for Medical Research (NIMR) of 
Tanzania (reference no. NIMR/HQ/R.8c/Vol.II/436), and the methods used in this study 
were performed in accordance with the approved guidelines.
Data availability
Source data for Figures 3-4 and Extended Data Figures 2, 5-6, 9-10 are provided with the 
paper. All data are available from the corresponding author upon reasonable request.
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Extended Data
Extended Data Figure 1. Binding of Fc fusion proteins of inhibitory receptors to IEs
Erythrocytes infected with 3D7 (3D7 IEs), P. falciparum obtained from patient 1 (Patient 1 
IEs), or uninfected erythrocytes were stained with Fc fusion proteins of inhibitory receptors. 
As a control, IEs were stained with APC-labelled anti-human IgG Fc Abalone (Control). 
FSC: Forward-scattered light. The experiments were replicated twice.
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Extended Data Figure 2. Variability and stability of LILRB1 binding to IEs and LILRB1 
reporter activity
a, LILRB1 binding to schizont-stage P. falciparum-infected erythrocytes from patients with 
malaria in Figure 1a. b, LILRB1 binding to P. falciparum-infected erythrocytes at the ring, 
mid-trophozoite and schizont stages of P. falciparum-infected erythrocytes derived from 
patient 6 in Figure 1b. c, LILRB1 binding to schizont-stage P. falciparum-infected 
erythrocytes from the laboratory strains CDC1, K1, FCR3 and Dd2 shown in Figure 1c. d, 
GFP expression in LILRB1-expressing reporter cells upon stimulation with P. falciparum-
infected erythrocytes in Figure 3c. Data represent the mean ± s.d. of three independent 
experiments. e, Proportions of LILRB1-Fc- binding erythrocytes infected with clone 3D7-F2 
were analysed during 5 weeks of culture. The experiment was performed once.
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Extended Data Figure 3. Identification of the LILRB1-ligand
a, Diagram of LILRB1-ligand identification. A putative LILRB1 ligand was 
immunoprecipitated from IE ghosts using an LILRB1-Fc fusion protein and was identified 
using mass spectrometry analysis. b, Mass spectrometry of LILRB1-Fc immunoprecipitates. 
The observed m/z values of b-ions (red) and y-ions (blue) in the MS/MS spectra of the 
peptide FHEYDER present in RP-HPLC fractions of trypsin-digests of LILRB1 precipitates 
from IEs infected with F2 clones. The experiments were replicated twice. c, The observed 
m/z values of b-ions and y-ions in the MS/MS spectra of the peptide FHEYDER present in 
RP-HPLC fractions of trypsin-digests of LILRB1 precipitates. The predicted m/z values are 
shown for comparison. The differences between the m/z values for observed ions and the 
predicted values are shown.
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Extended Data Figure 4. Screening of RIFINs that bound the LILRB1-Fc or LAIR1-Fc fusion 
protein
a, IEs of 3D7 carrying RIFIN-transgenes were stained with the LILRB1-Fc fusion protein. 
RIFIN-transgenes are indicated in the figure. Red and shaded histograms indicate staining 
with LILRB1-Fc and control-Fc fusion proteins, respectively. b, IEs of 3D7 carrying RIFIN-
transgenes were stained with the LAIR1-Fc fusion protein. RIFIN-transgenes are indicated 
in the figure. Red and shaded histograms indicate staining with LAIR1-Fc and control-Fc 
fusion proteins, respectively. Presence of the FHEYDER sequence in each RIFIN is 
indicated in the figure. Representative data from independent analyses are shown. Therefore, 
the proportions of IEs bound to Fc-fusion proteins and the levels of Fc-fusion protein 
binding IEs may not be comparable among different RIFINs. All experiments were 
replicated twice.
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Extended Data Figure 5. Expression of RIFINs in transgenic malaria parasites
a, The rif transgene transcript levels normalised to the internal control gene. The average of 
RIFIN #1 transcript levels was defined as 1. Data represent the mean ± s.d. (n = 3 
technically independent samples). RIFIN #6 expression was lowest among the transgenes. 
However, cell surface expression of RIFIN #6 was detected using a mutated LAIR1-Fc 
fusion protein (Extended Data Fig. 8a), indicating that all the transgenes were sufficiently 
expressed at the transcript level. b, Western blot analysis of the expression of transfected C-
terminally His-tagged RIFINs transfected in malaria parasites using an anti-His-tag mAb. 
The His-tagged RIFINs were detected at approximately equal levels (Supplementary Data). 
The expected molecular masses are 31.7 (RIFIN #1), 32.9 (RIFIN #2) and 34.8 (RIFIN #5) 
kDa. The experiment was performed once. c, P. falciparum-infected erythrocytes expressing 
C-terminally His-tagged RIFIN-transgenes RIFIN #1: PF3D7_1254800, RIFIN #2: 
PF3D7_0223100 and RIFIN #5: PF3D7_1254200 were stained with LILRB1-Fc (red) and 
control-Fc (shaded). The experiments were replicated at least twice.
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Extended Data Figure 6. Recombinant RIFINs
a, Binding of recombinant RIFINs to LILRB1 that was produced using a wheat germ cell-
free protein expression system. 293T cells expressing transfected LILRB1 or LILRA2 were 
stained with recombinant His-tagged RIFINs that were produced using a wheat germ cell-
free protein expression system. LILRA2 is an activating counterpart of LILRB1 and was 
used as a control. Red and blue histograms indicate binding of LILRB1+RIFIN #1 and 
LILRB1−RIFIN #5, respectively. The shaded histogram represents an unstained control. The 
experiments were replicated at least twice. b, Production of recombinant RIFINs in 
Escherichia coli.N-terminal-His-tagged variable regions of RIFINs were expressed in E. coli 
and purified using TALON metal-affinity chromatography. Recombinant RIFINs were 
analysed using SDS-PAGE and Oriole staining. LILRB1+RIFIN #1 and LILRB1−RIFIN #5 
are shown on the right and left, respectively. The experiments were replicated at least twice. 
c, Circular dichroism (CD) spectra of recombinant RIFINs. Refolded and purified 
recombinant RIFIN #1 and #5 were subjected to CD spectral analysis. The spectra are 
shown as the mean residue ellipticity after subtracting the solvent background. RIFINs #1 
and #5 exhibited CD spectra typical for well-folded proteins with α-helix (208 nm +222 nm) 
and β-sheet (215 nm) structures. Prediction of the secondary structures of each RIFIN using 
the BeStSel server (http://bestsel.elte.hu/index.php) yielded α/β values of ∼30%/∼10% and 
∼30%/∼20% for RIFINs #1 and #5, respectively. The experiment was performed once.
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Extended Data Figure 7. LILRB1-binding RIFIN did not bind to other LILRs
a, The sequence encoding the variable region of LILRB1+ RIFIN #1 was transfected into 
293T cells, and the transfectants were stained with LILR-Fc fusion proteins. The levels of 
LILR-Fc-binding are indicated in the figureas mean fluorescence intensities (MFIs). Control 
indicates fluorescence of cells reacted only with the secondary antibody. The experiment 
was performed once. b and c, Binding of LILR-Fc fusion proteins to IEs. RIFIN #1- and 
RIFIN #5-transgenic IEs were stained with 11 LILR-Fc fusion proteins and analysed using 
flow cytometry. Control indicates fluorescence of cells reacted only with the secondary 
antibody. The proportions of IEs stained with LILR-Fc fusion proteins are shown. The 
experiment in b was replicated twice and experiment in c was performed once.
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Extended Data Figure 8. Binding of wild-type and mutated LAIR1 to IEs
a, IEs from the RIFIN-transgenic parasites RIFIN #1: PF3D7_1254800, RIFIN #2: 
PF3D7_0223100, RIFIN #3: PF3D7_0500400, RIFIN #4: PF3D7_1000500, RIFIN #5: 
PF3D7_1254200, RIFIN #6: PF3D7_1400600, RIFIN #7: PF3D7_1040300 and RIFIN #8: 
PF3D7_1101100 were stained with wild-type LAIR1-Fc (wtLAIR1-Fc, red), mutated 
LAIR1-Fc (muLAIR1-Fc, blue), and control-Fc (shaded histogram) fusion proteins. The 
experiments were replicated twice. b, LAIR1-Fc bound to erythrocytes infected with P. 
falciparum derived from Thai patients with malaria. Schizont-stage erythrocytes infected 
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with P. falciparum from patients with malaria and uninfected erythrocytes were stained with 
LAIR1-Fc (red dot) and control-Fc (black dot) fusion proteins, followed by Vybrant 
Green(VG) staining. Percentages of LAIR1-ligand-expressing IEs are shown. The 
experiments were replicated at least twice. c, Patterns of LILRB1 and LAIR1 binding to IEs 
derived from Thai patients with malaria. Schizont-stage IEs derived from Thai patients with 
malaria were stained with LAIR1-Fc (vertical) and LILRB1-Fc (horizontal) fusion proteins, 
followed by VG staining. VG-positive cells were analysed. The percentages of LAIR1-
ligand single-positive, LILRB1-ligand single-positive and LAIR- and LILRB1-ligand 
double-positive IEs. The experiments were replicated twice.
Extended Data Figure 9. Functional analysis of cells expressing LAIR1 and LILRB1
a–c, Erythrocytes infected with LAIR1-Fc-binding parasites (RIFIN #8 transgenic parasites 
[a], parasites from Thai patient 1 [b], LAIR1-Fc-binding parasites enriched by cell sorting 
from Thai patient isolate 4 [LAIR1-L enriched patient 4, c]) or erythrocytes infected with 
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parasites that did not bind LAIR1-Fc (RIFIN #3 transgenic parasites [a], parasites from Thai 
malaria patient 3 [b, c]) were prepared (left histogram). LAIR1-reporter cells were co-
cultured with these IEs and their expression levels in reporter cells were analysed using flow 
cytometry (right dot plots). Immobilised collagen IV served as a positive control for LAIR1-
reporter activation. Proportions of GFP-expressing cells are shown as the mean ± s.d. (n = 3 
biologically independent samples, one-way ANOVA with Tukey's post hoc test).d, LILRB1 
expressed by the NK cell line NKL. e, FLAG-tagged RIFINs were expressed by K562 cells 
stably transfected with LILRB1+ RIFIN #1 or LILRB1− RIFIN #5. f, RIFIN-K562 cells or 
parental K562 cells were used as targets for NKL. The E:T ratio indicates the Effector: 
Target ratio. Data represent the mean ± s.d. (n = 3 technically independent samples). *P < 
0.05, two-way ANOVA with Tukey's post hoc test. SSC: Side-scattered light. The 
experiments in d and e were replicated at least twice.
Extended Data Figure 10. Age dependence of the antibody response to LILRB1+ and LILRB1− 
RIFINs
Plasma IgG positivity for the recombinant proteins comprising the variable regions of 
LILRB1+ RIFIN #1 and LILRB1− RIFIN #5 as well as GLURP_R2 in 222 Tanzanian 
individuals divided into age groups. Error bars represent 95% CI.P values were calculated 
using logistic regression comparing percent responders among children aged 0-1 years to 
children of the other age groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Plasmodium falciparum-infected erythrocytes (IEs) are recognised by LILRB1
a, Analysis of IEs with an LILRB1-Fc fusion protein. Diagram of LILRB1-Fc binding to 
IEs. Schizont-stage P. falciparum IEs and uninfected erythrocytes were stained with 
LILRB1-Fc (red dot) and control-Fc (black dot), followed by Vybrant Green (VG) staining. 
Percentages of LILRB1-binding IEs are shown. b, Different stages of P. falciparum IEs 
derived from patient 6 were stained with LILRB1-Fc, followed by VG staining. Percentages 
of LILRB1-positive IEs are shown. c, Schizont-stage IEs from four P. falciparum laboratory 
strains were stained with LILRB1-Fc (red) and control-Fc (shaded), followed by VG 
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staining. Percentages of LILRB1-binding IEs are shown. d, LILRB1-binding clone 3D7 (F2) 
and non-binding clone 3D7 (D11). Red and shaded histograms indicate staining with 
LILRB1-Fc and control-Fc, respectively. Data represent at least three independent 
experiments and the variabilities of data shown a, b and c are shown in Extended Data 
Figure 2a, 2b and 2c, respectively.
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Figure 2. RIFINs are ligands for LILRB1 and LAIR1
a, Diagram of the method used to generate transgenic P. falciparum. LILRB1-Fc and 
LAIR1-Fc bind IEs expressing RIFIN-transgenes. RIFIN-transgenic parasites are RIFIN #1: 
PF3D7_1254800, RIFIN #2: PF3D7_0223100, RIFIN #3: PF3D7_0500400, RIFIN #4: 
PF3D7_1000500, RIFIN #5: PF3D7_1254200, RIFIN #6: PF3D7_1400600, RIFIN #7: 
PF3D7_1040300 and RIFIN #8: PF3D7_1101100. Red, blue and shaded histograms indicate 
staining with LILRB1-Fc, LAIR1-Fc and control-Fc, respectively. b, Amino acid sequence 
alignments of RIFINs that bind LILRB1, LAIR1 or neither. SP and TM indicate the signal 
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peptide and transmembrane domains, respectively. Green, blue, red and black characters 
indicate hydrophobic, basic, acidic and neutral amino acid residues, respectively. The 
FHEYDER sequence is contained in the red box. c, N-terminally FLAG-tagged conserved or 
variable regions of LILRB1+ RIFIN #1 fused to the PILRα transmembrane region (TM) 
expressed by 293T cells were tested for LILRB1-Fc binding (upper panel). RIFIN 
expression was detected using an anti-FLAG antibody (lower panel). Red and shaded 
histograms indicate RIFIN and mock (GFP) transfectants, respectively. d, LILRB1-
transfected 293T cells were stained with His-tagged LILRB1+ RIFIN #1 or LILRB1− 
RIFIN #5, followed by staining with an anti-His antibody. Data represent at least three 
independent experiments.
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Figure 3. Inhibition of LILRB1-expressing B cells by RIFIN
a, Diagram of the LILRB1 NFAT-GFP reporter assay. b, GFP expression in LILRB1-
reporter cells upon treatment with recombinant RIFIN. Red histograms indicate treatment 
with recombinant LILRB1+ RIFIN#1 or LILRB1− RIFIN#5. Shaded histogram areas 
represent medium alone. c, GFP expression in LILRB1-reporter cells upon treatment with 
IEs expressing the LILRB1+ RIFIN #1 or LILRB1− RIFIN #4 transgene. Percentages of 
GFP-expressing cells are shown. SSC: Side-scattered light. d, Red and shaded histograms 
indicate staining of primary human B cells from a healthy donor with an anti-LILRB1 
antibody and control, respectively. e, Inhibition of human immunoglobulin M (IgM) 
production in PBMCs by IEs. Human PBMCs were co-cultured with IEs, and IgM was 
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measured in culture supernatants (mean ± s.d.). Transgenic malarial parasites expressing 
LILRB1+ RIFIN #1, LILRB1− RIFIN #4 or mock (GFP) are shown. Control indicates 
PBMCs alone. n = 3 technically independent samples. f, Inhibition of human IgM 
production by RIFIN-transfected CHO cells. PBMCs were co-cultured with CHO cells 
expressing LILRB1+ RIFIN #1, LILRB1− RIFIN #3 and an unrelated gene (MDA5). Data 
represent the mean ± s.d. (n = 3 technically independent samples). *P< 0.05 (one-way 
ANOVA with Tukey's post hoc test). Data represent at least three independent experiments, 
and the variability of data presented in c is shown in Extended Data Fig.2d.
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Figure 4. Binding of Plasmodium falciparum-infected erythrocytes to LILRB1 is associated with 
severe malaria
a, Binding of IEs from Tanzanian patients with malaria diagnosed with cerebral malaria, 
severe anaemia or both (severe malaria, n = 9) or non-cerebral or non-severe anaemia (non-
severe malaria, n = 30) to LILRB1-Fc, relative to control-Fc (median, 75 and 95 percentiles 
and two-sided Mann–Whitney U test). b, Diagram of the suggested mechanism of immune 
evasion. P. falciparum induces the expression of RIFINs on the surface of IEs. Individual 
RIFINs may have evolved to target host inhibitory receptors, thus facilitating escape from 
host immune systems, which may lead to inefficient development of immunity.
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